American woman, child freed after being kidnapped in Haiti last month

0:26InthisundatedphotoprovidedbyElRoiHaiti,AlixDorsainvil,right,poseswithherhusband,SandroDorsainvil EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest




hotspot

author：hotspot    Page View：48
Alexis Borisy
Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

advertisement

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In
Previous article： The HPV vaccine prevents cancer in men, too. Why do so few people get it?
Next article： The cancer drug shortage isn’t new — and neither are the solutions